Insulet
PODD
#1965
Rank
$10.16 B
Marketcap
$146.51
Share price
-6.16%
Change (1 day)
-54.27%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $1.72

According to Insulet's latest financial reports the company's current EPS (TTM) is $4.23. In 2022 the company made an earnings per share (EPS) of $0.07000 a decrease over its 2021 EPS that were of $0.23.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.722357.14%
2022$0.07000-69.57%
2021$0.23109.09%
2020$0.11-38.89%
2019$0.18200%
2018$0.06000-113.04%
2017-$0.46-9.8%
2016-$0.51-60.77%
2015-$1.3039.78%
2014-$0.9312.05%
2013-$0.83-23.15%
2012-$1.0810.2%
2011-$0.98-36.36%
2010-$1.54-36.63%
2009-$2.43-29.36%
2008-$3.44-86.74%
2007-$25.95-64.04%
2006-$72.15122.23%
2005-$32.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$2.70-36.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$4.08-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$30.87 629.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-$0.93-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
$1.20-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$2.59-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA